EMAIL: [email protected]
PHONE: 720.213.5824

Nick Thomas

Nick has an extensive journalism background, having worked in a variety of media and industries including as a reporter on the UK utilities sector for Bloomberg in London. He was also an early employee for successful digital M&A company Mergermarket where he served as the Content Editor. Originally from the UK, he has a BA in modern languages from the University of Wales (Bangor) and an MA in international studies from the University of Denver.

Charlotte’s Web reports improved quarterly revenues, lower net income

Charlotte’s Web Holdings, which makes whole-plant hemp health supplements, reported quarterly revenues of $21.7 million for the three months ended March 31, up almost 66% from the corresponding period last year ($13.1 million). The Boulder, Colorado-based company reported net income of $2.3 million for the period, compared with $3.1 million last year. Charlotte’s Web trades […]

Read More

Charlotte’s Web closes CA$140 million share offering

Charlotte’s Web, a Colorado-based CBD manufacturer, said it has raised 140 million Canadian dollars ($105 million) in a share offering. The move, in which existing shareholders sold some of their shares, was part of the company’s plans to raise up to CA$500 million. The overall raise will likely be used for possible acquisitions, funding ongoing […]

Read More

Sanitas Peak to invest $3M in hemp producer Colorado Cultivars

Sanitas Peak, a Boulder, Colorado-based investment group, said it has placed a $3 million debt facility with Colorado Cultivars, a producer of industrial hemp. Proceeds from the loan primarily will be used to develop production and processing facilities at the company’s main farm in Eaton, Colorado. Colorado Cultivars grew 1,500 acres of hemp in 2018 […]

Read More

Arizona payments processor to serve hemp, CBD businesses

While other banks and payment processors are stepping back, Hypur, an Arizona-based payments processor, has launched services to serve hemp and CBD merchants throughout the United States. Elavon, a U.S. Bank payments solution subsidiary, recently announced it would withdraw its services to the sector because of concerns over federal regulations. Other payment processing companies such as […]

Read More

Hemp companies left looking for banking alternatives

The stability that the 2018 Farm Bill was supposed to bring to the hemp industry remains elusive, particularly on the banking front, where a risk-averse industry has been pulling its previously dipped toes out of the water. U.S. Bank’s payments processing subsidiary Elavon recently opted to pull out of offering services to hemp farmers and […]

Read More

Confusion, enthusiasm combine at Hemp Investor Forum

Uncertainties surrounding regulations – both at the state and federal levels – and a lack of recent historic data in the United States are factors that could discourage investors in the American hemp industry, attendees at a Denver forum heard last week. However, savvy investors can still find opportunities in “one of the most unique […]

Read More

Hemp manufacturer Charlotte’s Web explores uplisting to TSX, US stock exchanges

Charlotte’s Web, the Colorado-based hemp and CBD company, is continuing to explore the possibility of either uplisting to either the Toronto Stock Exchange or U.S. exchanges. Various options are being looked at, including a possible listing on the New York Stock Exchange, CEO Hesaam Moallem told analysts on a conference call to discuss the company’s […]

Read More

Arizona hemp farmers get green light to plant in June

Hemp farmers in Arizona can now begin planting two months earlier than originally planned, thanks to a bill signed into law by Gov. Doug Ducey. State Sen. Sonny Borrelli of Lake Havasu City sponsored the bill, which could permit farmers to plant as early as June rather than waiting for August, as set by another bill […]

Read More

GW Pharma denies supply issues with cannabis-based drug Epidiolex after stock falls

GW Pharmaceuticals, the British maker of epileptic seizure-control medication Epidiolex, said it was not aware of any supply issues related to the cannabis-derived drug after a tweet from a patient’s father complained he could not source the medicine. GW’s stock was down more than 3% on Wednesday on the Nasdaq after the tweet from San […]

Read More